Oncologix Tech, Inc.
Oncologix Tech, Inc. (OCLG) Shares Outstanding — Overview
Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.
OCLG · shares outstanding · updated Jun 10, 2026
Key metrics
as of Aug 31, 2017Shares Outstanding Growth Rate
CAGR · weighted avg basic sharesNegative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials
Shares outstanding history
Annual shares outstanding by year
Financial Services sector shares outstanding comparison
Shares Outstanding for similar companies or competitors in the Financial Services sector.
BAC
JPM
BRK-B
V
MAOCLG
BRK-A/company-screener · per-peer /income-statement · cache 86400s
Understanding Shares Outstanding
Basic · Diluted · FloatWhat Are Shares Outstanding? (Basic)
Oncologix Tech, Inc. (OCLG) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of August 31, 2017, Oncologix Tech, Inc. reports 736.6M basic shares outstanding (weighted average).
Basic vs. Diluted Shares Outstanding
Oncologix Tech, Inc.'s basic shares outstanding (736.6M) represents currently issued shares. Diluted shares outstanding (736.6M) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.
Shares Outstanding vs. Float (Free Float)
Oncologix Tech, Inc.'s float is — (— of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.
ⓘ Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.
FMP /income-statement · /shares-float · SEC EDGAR · USD
About shares outstanding & methodology
Oncologix Tech, Inc. (OCLG) shares outstanding history from 1998 to 2017. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.
Oncologix Tech, Inc. shares outstanding for the fiscal year ending August 31, 2017 were 736.6M, a 2.33% increase year-over-year. Oncologix Tech, Inc. FY 2017 shares outstanding were 736.6M, a +2.33% increase from FY 2016.
Oncologix Tech, Inc. is a leading company operating in the Financial Services sector. The company's share count trajectory — with a 10-year CAGR of +46.1% — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.
Frequently asked questions
OCLG shares outstanding · 4 questionsAs of August 31, 2017, Oncologix Tech, Inc. (OCLG) has approximately 736.6M basic shares outstanding and 736.6M diluted shares outstanding. This represents a +2.33% year-over-year increase from FY 2016 (719.8M). The increase may reflect equity compensation issuances or secondary offerings.
▸ Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · Oncologix Tech, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-10